Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials.

Sethi, Sanjay

Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials. [electronic resource] - Therapeutic advances in respiratory disease - 1753466620905278 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1753-4666

10.1177/1753466620905278 doi


Administration, Inhalation
Adrenal Cortex Hormones--administration & dosage
Adrenergic beta-Agonists--administration & dosage
Aged
Benzamides--administration & dosage
Bronchodilator Agents--administration & dosage
Carbamates--administration & dosage
Clinical Trials, Phase III as Topic
Drug Administration Schedule
Drug Therapy, Combination
Female
Forced Expiratory Volume
Humans
Lung--drug effects
Male
Middle Aged
Muscarinic Antagonists--administration & dosage
Nebulizers and Vaporizers
Pulmonary Disease, Chronic Obstructive--diagnosis
Randomized Controlled Trials as Topic
Recovery of Function
Time Factors
Treatment Outcome